References
- Beksac M S, Khan S A, Eliasson R, Skakkabaek N E, Sheth A R, Diczfalusy E. Evidence for the prostatic origin of immunoreactive inhibin-like material in human seminal plasma. Int J Androl 1984; 7: 389–397
- Carlstrom K, Skoldefors H, Tollbom O. Metabolism of estrone sulphate by benign prostatic hyperplasia in vitro. Scand J Urol Nephrol 1980; 14: 135–137
- DeKlerk D P. Human trials of endocrine management. Benign Prostatic Hypertrophy, F Hinman, Jr. Springer-Verlag, New York 1984; 262–270
- Doctor V M, Sheth A R, Simha M M, Arbatti N J, Zaveri J P, Sheth N A. Studies on immunocytochemical localization of inhibin-like material in human prostatic tissue: Comparison of its distribution in normal, benign and malignant prostates. Br J Cancer 1986; 53: 547–554
- Ewing L L, Thompson D L, Cochran R C, Lastey B L, Thompson M A, Zirkin B A. Testicular androgen and estrogen secretion and benign prostatic hyperplasia in the beagle. Endocrinology 1984; 114: 1308–1314
- Greenwood F C, Hunger W M, Glover J S. The preparation of I-labelled human growth hormone of high specific radioactivity. Biochem J 1963; 89: 114–123
- Habenicht U F, Schwarz K, Schweikert H U, Neumann F, Eletreby M F. Development of a model for the induction of estrogen-related prostatic hyperplasia in the dog and its response to the aromatase inhibitor 4-hydroxy-4-androstene-3,17-Dione: Preliminary results. Prostate 1986; 3: 181–194
- Joseph R, Maitra A B, Moodbidri S B, Sheth A R. Effect of inhibin on testosterone metabolism by rat ventral prostate in vitro. Arch Androl 1987; 18: 205–210
- Karr J P, Murphy G P. Cellular growth and hormone receptor. Benign Prostatic Hypertrophy, F Hinman, Jr. Springer-Verlag, New York 1983; 193–214
- Kharbanda K, Kumari M, Mohapatra S, Duraiswami S. Extragonadal secretion of an inhibin-like substance in the laboratory albino rat. J Biosci 1985; 7: 115–122
- Kozak I, Bartsch W, Kreig M, Voigt K D. Preferential accumulation of estradiol in stromal nuclei of human benign prostatic hyperplasia (BHP). Acta Endocrinol (Copenh) 99: Suppl 1982; 246: 128–129
- Krieg M, Klotzl G, Kaufmann J, Voigt K D. Stroma of human benign prostatic hyperplasia: Preferential tissue for androgen metabolism and estrogen binding. Acta Endocrinol (Copenh) 1981; 96: 422–432
- Krieg M. Biochemical endocrinology of human prostatic tumors. Progress in Cancer Research Therapy, F Bresciani. Raven, New York 1984; Vol 31: 425–440
- Lowry O H, Rosebrough N J, Farr A L, Randall R J. Protein measurement with folin phenol reagent. J Biol Chem 1951; 193: 265–275
- Lee C H, Jesik C. Effects of castration, estrogen and androgen administration. Benign Prostatic Hypertrophy, F Hinman, Jr. Springer-Verlag, New York 1983; 229–234
- McNeal J E. Morphology and biology of benign prostatic hyperplasia. Regulation of Androgen Action, N Bruchovsky, A Chapdelaine, F Neumann. Congressdruck R Bruckner, West Berlin 1985; 23–30
- Natraj U, Vanage G R, Didolkar A K, Moodbidri S B, Sheth A R. Stimulation of ornithine decarboxylase in rat prostate with inhibin. Int J Androl 1986; 9: 218–228
- Neubauer B L. Endocrine and cellular factors in the development of human benign prostatic hypertrophy. Benign Prostatic Hypertrophy, F Hinman, Jr. Springer-Verlag, New York 1983; 179–192
- Rohr H P, Bartsch G. Human benign prostatic hyperplasia. A stromal disease? New perspectives by quantitative morphology. Urology 1980; 6: 625–633
- Sathe V S, Sheth A R, Sheth N A. Biosynthesis of immunoreactive inhibin-like material (IR-ILM) by rat prostate. Prostate 1986; 8: 401–408
- Schweikert H U. Conversion of androstenedione to estrone in human fibroblasts cultured from prostate, genital and non-genital skin. Horm Metab Res 1979; 11: 635–640
- Shanbhag S A, Sheth A R, Nanivadekar S A, Sheth N A. Studies on inhibin-like peptide in gastric juice and serum of patients with duodenal ulcers. J Endocrinol 1984; 103: 389–393
- Sheth A R, Panse G T, Vaze A Y, Geller J, Albert J. Inhibin in human prostate. Arch Androl 1981; 6: 317–321
- Sheth N A, Khedkar V M, Kulkarni J N, Kamat M R, Sheth A R. Serum inhibin in patients with neoplastic prostate. Arch Androl 1982; 9: 215
- Sheth N A, Doctor V M, Sampat M B, Garde S V, Arbatti N J, Sheth A R. Inhibin-like material–an immuno-histologic marker for prostatic origin of metastases. Cancer Let 1987; 36: 93–98
- Thakur A N, Vaze A Y, Dattatreyamurthy B, Sheth A R. Isolation and characterization of inhibin from human seminal plasma. Indian J Exp Biol 1981; 19: 307–313
- Wenderoth U K, Griffin J E, Wilson J D. Normal and hyperplastic human prostates concentrate estradiol. Acta Endocrinol (Copenh) 99:Suppl 1982; 246: 246
- Wilson J D. The pathogenesis of benign prostatic hyperplasia. Am J Med 1980; 68: 745–756
- Vaze A Y, Thakur A N, Sheth A R. Development of a radioimmunoassay for human seminal plasma inhibin. J Reprod Fertil (Suppl) 1979; 26: 135–146
- Vaze A Y, Thakur A N, Sheth A R. Levels of inhibin in human semen and accessory reproductive organs. Andrologia 1980; 12: 66–71
- Vermeulen A. Testicular hormonal secretion and aging in mammals. Benign Prostatic Hyperplasia, J T Grayhack, J D Wilson, M J Sherbenske. DHEW Publication (NIH), Washington 1975; 177–181